Using Technology to Affect Influenza Vaccine Coverage Among Children With Chronic Respiratory Conditions.

Using Technology to Affect Influenza Vaccine Coverage Among Children With Chronic Respiratory Conditions.

J Pediatr Health Care. 2016 Jul 27;

Authors: Bay SL, Crawford DJ

Abstract
INTRODUCTION: Influenza presents additional burdens for children with chronic respiratory conditions. Influenza vaccinations may reduce complications, yet approximately half of children remain unprotected. Evidence supports integration of text and e-mail into multicomponent strategies to increase influenza vaccination rates among children with chronic respiratory conditions.
METHODS: A single text and e-mail message was sent to those with enabled preferences in the patient portal. A follow-up survey assessed aspects of message receipt. Surveys were completed without collection of demographics.
RESULTS: A total of 3,206 messages were successfully delivered. Surveys were initiated by 107 recipients. Frequency analysis showed that text and e-mail messages were preferred forms of communication. A statistically significant relationship was found between receiving a message and receiving an influenza vaccination (p = .027).
DISCUSSION: Text and e-mail messaging are cost effective and well received, and they can be easily integrated into existing systems. These methods are translatable across populations and can convey various types of messages.

PMID: 27475928 [PubMed – as supplied by publisher]

View full post on pubmed: asthma

Propeller Health’s Digital Asthma Technology Gets High Marks in Controlled Study by Dignity Health – Lung Disease News


Lung Disease News

Propeller Health's Digital Asthma Technology Gets High Marks in Controlled Study by Dignity Health
Lung Disease News
Dignity Health, a national leader in healthcare systems, recently announced the results of a randomized, controlled study, indicating the use of digital health technology — namely the Propeller Health Asthma Platform — as an effective strategy to

View full post on asthma – Google News

Dignity Health Improves Asthma Outcomes with Use of Digital Health Technology – Business Wire (press release)

Dignity Health Improves Asthma Outcomes with Use of Digital Health Technology
Business Wire (press release)
SAN FRANCISCO–(BUSINESS WIRE)–Dignity Health, one of the nation's largest health care systems, announced results from a randomized controlled study which demonstrated that the use of digital health technology improved asthma control. The study …

and more »

View full post on asthma – Google News

Northwestern Medicine develops new technology to treat allergies, asthma – Daily Northwestern


KMBC Kansas City

Northwestern Medicine develops new technology to treat allergies, asthma
Daily Northwestern
Northwestern Medicine researchers developed a new technology that can be used to disable food allergies and asthma. The new method includes a biodegradable nanoparticle concealing allergens from the immune system by coating them in a “friendly …
Doctor On Demand, Allergy & Asthma Network Team Up To Make Treating Asthma and Allergies Easier for MillionsPR Newswire (press release)
Spring Asthma & Allergy TipsKMBC Kansas City
5 tips to breathe easy this springQuad-Cities Online
Royal Gazette –CNN
all 27 news articles »

View full post on asthma – Google News

FDA Approves Teva’s Cinqair for the Treatment of Severe Asthma – Pharmaceutical Technology Magazine (press release) (blog)


Lung Disease News

FDA Approves Teva's Cinqair for the Treatment of Severe Asthma
Pharmaceutical Technology Magazine (press release) (blog)
FDA approved Teva Pharmaceutical's Cinqair (reslizumab) on March 23, 2016 for use with other asthma medicines for the maintenance treatment of severe asthma in patients 18 years and older. Cinqair is approved for patients who have a history of severe …
FDA Approves Teva's Asthma Drug Cinqair as Add-on TreatmentLung Disease News
Nucala and Cinqair for the Treatment of Severe AsthmaAbout – News & Issues

all 3 news articles »

View full post on asthma – Google News

Advancements in Devices and Particle Engineering in Dry Powder Inhalation Technology.

Related Articles

Advancements in Devices and Particle Engineering in Dry Powder Inhalation Technology.

Curr Top Med Chem. 2016 Feb 15;

Authors: Vadakkan MV, Vinod Kumar GS

Abstract
Dry powder inhalers (DPI) attracted the attention of pharmaceutical field due to its enlarging market share in inhalable formulations. These formulations also pose patient compliance and good shelf life. Earlier DPI formulations were intended for local effect in lung (asthma and chronic obstructive pulmonary diseases), whereas 21st century witnessed formulations intended for systemic effect too. A better understanding of physiology of lung and fluidics of air flow helped in targeting alveoli using DPI technology. Modern characterization tools also accelerated the research pace. In addition to the synthetic molecules, DPI also was proved to be a better system for delivering biological molecules including vaccines. This review includes the mechanisms of drug deposition, advancements in the fields of DPI devices, various characterization tools and particle engineering. In this review we have related the chronological advancement of inhalational technology starting from 1788 AD to the present.

PMID: 26876523 [PubMed – as supplied by publisher]

View full post on pubmed: asthma

$6 million grant will help UCLA–USC team develop kid-friendly technology to … – UC Los Angeles


UC Los Angeles

$6 million grant will help UCLA–USC team develop kid-friendly technology to
UC Los Angeles
Asthma is the most common chronic condition in children, and it weighs heavily on the nation in terms of public health, medical costs and quality of life,” said Alex Bui, a professor of radiological sciences at the David Geffen School of Medicine at

View full post on asthma – Google News